Skip to main content
OpenTrials
Completed

NCT Number: NCT03494582

Abdominal Versus Vaginal Hysteropexy

This study will compare the vaginal versus the abdominal approach for the management of uterine prolapse

Completed

Looking for future studies?

Notify Me

Key information

About this study

this study compares The unilateral sacrospinous hysteropexy with prolene sutures versus the abdominal sacral hysteropexy using Mersilene suture for the management of uterine prolapse

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Uterine Prolapse

Exclusion criteria

  • Previous prolapse surgery Hereditary Connective tissue disorders

Treatment and study plan

Sacral Hysteropexy

Procedure

Abdominal approach for uterine suspension

sacrospinous Hysteropexy

Procedure

Transvaginal approach for uterine suspension

Primary outcomes

  1. Pelvic organ prolapse quantification system

    Time frame: 3 month

    compare Pelvic organ prolapse quantification system between groups

Secondary outcomes

  1. Perioperative data

    Time frame: 1 day

    operative time

  2. operative details

    Time frame: 1 day

    blood loss

Sponsors and collaborators

Lead sponsor

Ain Shams Maternity Hospital

Other

Registry information

Official study title

Trans Vaginal Sacrospinous Hysteropexy Versus Abdominal Sacral Hysteropexy for the Management of Uterine Prolapse

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Apr 11, 2018
Registry last updated
Dec 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.